Results 11 to 20 of about 41 (37)

Phase II trial of multi-kinase inhibitor ESK981 in patients with metastatic castration-resistant prostate cancer. [PDF]

open access: yesInvest New Drugs
Heath EI   +11 more
europepmc   +1 more source

Atezolizumab following definitive chemoradiotherapy in patients with unresectable locally advanced esophageal squamous cell carcinoma - a multicenter phase 2 trial (EPOC1802). [PDF]

open access: yesNat Cancer
Bando H   +28 more
europepmc   +1 more source

Microbiota-driven antitumour immunity mediated by dendritic cell migration. [PDF]

open access: yesNature
Lin NY   +35 more
europepmc   +1 more source

Predicting cytogenetic risk in multiple myeloma using conventional whole-body MRI, spinal dynamic contrast-enhanced MRI, and spinal diffusion-weighted imaging. [PDF]

open access: yesInsights Imaging
Van Den Berghe T   +13 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions

Ca-A Cancer Journal for Clinicians, 2021
Heather A Parsons   +2 more
exaly  

Sources, resolution and physiological relevance of R-loops and RNA–DNA hybrids

Nature Reviews Molecular Cell Biology, 2022
Eva Petermann, Li Lan, Lee Zou
exaly  

Home - About - Disclaimer - Privacy